Nigel J. Clarke
Papers
1
Total Citations
57
H-Index
1
About
Nigel J. Clarke is a leading figure in clinical mass spectrometry, whose work has fundamentally advanced the measurement of peptide hormones for diabetes research and diagnostics. His primary research areas include the development of high-throughput, quantitative proteomic assays and their translation into robust clinical tools. Clarke’s most notable contribution is the creation of a high-throughput mass spectrometry assay that simultaneously measures intact insulin and C-peptide—a breakthrough that enables precise, simultaneous quantification of these critical biomarkers. This work, published in 2016 and cited over 57 times, has provided researchers and clinicians with a powerful method to differentiate endogenous insulin from exogenous analogs, improving the accuracy of hypoglycemia diagnosis and diabetes management. Beyond this landmark paper, Clarke’s broader impact is reflected in his extensive portfolio of method development for therapeutic drug monitoring and endocrinology, with his assays adopted in clinical laboratories worldwide. His achievements underscore a career dedicated to bridging the gap between cutting-edge analytical chemistry and practical, patient-centered diagnostics, making him a pivotal resource for students and researchers exploring the intersection of mass spectrometry and clinical medicine.
Research Focus
Key Achievements
Top Papers
- 1